Literature DB >> 22470210

Progressive and extensive ulcerations in a girl since 4 months of age: the difficulty in diagnosis of pyoderma gangrenosum.

Nilendu Sarma1, Syamal Kumar Bandyopadhyay, Anup Kumar Boler, Medhatithi Barman.   

Abstract

A female child developed multiple, progressive, therapy-resistant, painful large ulcers, vesicles, and pustules since her 4 months of age. The ulcers were large, some even measured more than 8 cm; most had violaceous undermined margin with surrounding erythematous halo, raw and crusted surface and were distributed extensively over scalp, face, ear, trunk, buttocks, thigh, legs, dorsum of hands, and feet without any mucosal involvement. After detail clinical examination and investigation, it was diagnosed as a case of pyoderma gangrenosum. Extensive search did not reveal any systemic abnormality or detect any infective etiology. The case highlights the problems of diagnosis of multiple ulcers at very early age.

Entities:  

Keywords:  Children; diagnosis; pyoderma gangrenosum

Year:  2012        PMID: 22470210      PMCID: PMC3312658          DOI: 10.4103/0019-5154.92678

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  4 in total

Review 1.  Skin ulcers misdiagnosed as pyoderma gangrenosum.

Authors:  Roger H Weenig; Mark D P Davis; Patrick R Dahl; W P Daniel Su
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

2.  Pyoderma gangrenosum: a report of 44 cases with follow-up.

Authors:  P von den Driesch
Journal:  Br J Dermatol       Date:  1997-12       Impact factor: 9.302

3.  Giant cells in pyoderma gangrenosum.

Authors:  S Sanders; S R Tahan; T Kwan; C M Magro
Journal:  J Cutan Pathol       Date:  2001-02       Impact factor: 1.587

Review 4.  Delayed diagnosis of pyoderma gangrenosum: a case study.

Authors:  Jose Contreras-Ruiz; Nicole S Kresch-Tronik; Maria Isabel de la Cruz-Garcia; Sergio Mercado-Ceja; Adriana Lozano-Platonoff
Journal:  Ostomy Wound Manage       Date:  2008-11       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.